Skip to main content
Andre Kalil, MD, Infectious Disease, Omaha, NE

Andre C Kalil MD

Infectious Disease•Omaha, NE

Associate Professor, Internal Medicine, University of Nebraska Medical

Join to View Full Profile

  • 988102 Nebraska Medical CtrOmaha, NE 68198

  • Phone+1 402-559-4015

  • Fax+1 402-559-5581

Are you Dr. Kalil?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Claim this profileNot you? Find your profile

Summary

  • Dr. Andre Kalil, MD is an infectious disease specialist in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, District of Columbia, and Maryland. He is an Associate Professor at University of Nebraska Medical.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital
    Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1996 - 1998
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 1995 - 1996
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991 - 1995

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2002 - 2026
  • MA State Medical License
    MA State Medical License 1996 - 2001
  • DC State Medical License
    DC State Medical License 1998 - 2000
  • FL State Medical License
    FL State Medical License 1993 - 2000
  • MD State Medical License
    MD State Medical License 1997 - 2000
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Remdesivir-Dexamethasone Tied to Fewer Deaths in Severe COVID
    Remdesivir-Dexamethasone Tied to Fewer Deaths in Severe COVIDSeptember 24th, 2024
  • Steroid Drug Reduces Death Rate in Severe Pneumonia, Study Shows
    Steroid Drug Reduces Death Rate in Severe Pneumonia, Study ShowsMarch 21st, 2023
  • FDA Approves Lilly and Incyte's OLUMIANT® (Baricitinib) for the Treatment of Certain Hospitalized Patients with COVID-19
    FDA Approves Lilly and Incyte's OLUMIANT® (Baricitinib) for the Treatment of Certain Hospitalized Patients with COVID-19May 11th, 2022
  • Join now to see all

Dr. Andre Kalil, Dr. Andre Kalil, MD, Dr. A Kalil, Dr. Andre C Kalil